Mostafa Rasha Ezzat, Morsi Azza Hassan, Asaad Gihan Farag
Pharmacology Department, Medical Research Division, National Research Centre, Dokki, Cairo, Egypt.
Pathology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Res Pharm Sci. 2021 Aug 19;16(5):547-558. doi: 10.4103/1735-5362.323920. eCollection 2021 Oct.
The clinical use of the chemotherapeutic drug, doxorubicin (DXR), is significantly limited by its extensive multi-organ toxicity. Dipeptidyl peptidase-4 (DPP4) is over-expressed in oxidative stress, inflammation and apoptosis. DPP4 inhibitors have proven pleiotropic effects. The study investigates the protective effects of some DDP4 inhibitors; namely, saxagliptin (SAX) and vildagliptin (VIL) against DXR-induced nephrotoxicity in rats.
Forty rats were divided into 4 groups. Group I served as normal control. Nephrotoxicity was induced in the remaining 3 groups by single-DXR injection (15 mg/kg, i.p.). Groups III and IV administered oral SAX (10 mg/kg) and VIL (10 mg/kg) for 2 weeks.
FINDINGS/RESULTS: DXR-control rats showed deteriorated renal functions, elevated renal inflammatory parameters (tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and inducible nitric oxide synthase (iNOS)), up-regulated nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome and significant tubulointerstitial injury manifested by elevated neutrophil gelatinase-associated lipocalin concentration and distorted renal histopathological pictures. Immunohistochemical studies showed increased iNOS and Bax positivity in renal tissues of DXR-control rats. Treatment with SAX and VIL significantly attenuated DXR-induced nephrotoxicity alleviation of all the above-mentioned parameters when compared to DXR-control rats.
The study elucidated the possible mechanisms beyond DXR-induced nephrotoxicity to be through inflammation plus tubulointerstitial injury. DXR nephrotoxicity has been linked to TNF-α, IL-1β, and NLRP3 inflammasome up-regulation and iNOS expression. The protective role of SAX and VIL in mitigating the tubular injury and inflammatory effects of DXR on renal tissues has been tested and proved.
化疗药物阿霉素(DXR)的临床应用因广泛的多器官毒性而受到显著限制。二肽基肽酶-4(DPP4)在氧化应激、炎症和细胞凋亡中过度表达。DPP4抑制剂已被证明具有多效性。本研究调查了一些DPP4抑制剂,即沙格列汀(SAX)和维格列汀(VIL)对DXR诱导的大鼠肾毒性的保护作用。
40只大鼠分为4组。第一组作为正常对照组。其余3组通过单次腹腔注射DXR(15mg/kg)诱导肾毒性。第三组和第四组口服SAX(10mg/kg)和VIL(10mg/kg),持续2周。
DXR对照组大鼠肾功能恶化,肾脏炎症参数(肿瘤坏死因子α(TNF-α)、白细胞介素-1β(IL-1β)和诱导型一氧化氮合酶(iNOS))升高,含吡啉结构域3的核苷酸结合寡聚化结构域样受体(NLRP3)炎性小体上调,中性粒细胞明胶酶相关脂质运载蛋白浓度升高和肾脏组织病理学图像扭曲表明存在明显的肾小管间质损伤。免疫组织化学研究显示,DXR对照组大鼠肾组织中iNOS和Bax阳性增加。与DXR对照组大鼠相比,SAX和VIL治疗显著减轻了DXR诱导的肾毒性,上述所有参数均得到缓解。
本研究阐明了DXR诱导肾毒性的可能机制是通过炎症和肾小管间质损伤。DXR肾毒性与TNF-α、IL-1β、NLRP3炎性小体上调和iNOS表达有关。SAX和VIL在减轻DXR对肾组织的肾小管损伤和炎症作用方面的保护作用已得到验证。